25 Sept 2026, 17:05
Securities Administration—
XENXENITRA LIMITED
Announcement history available from 1 August 2025
Fromto
7 Sept 2026, 18:51
Securities Administration—
7 Sept 2026, 18:49
Securities Administration—
1 Sept 2026, 17:12
Securities Administration—
1 Sept 2026, 16:56
Securities Administration—
31 Aug 2026, 18:44
Company Administration—
31 Aug 2026, 17:50
Financial ResultsMS
24 Aug 2026, 09:57
Securities Administration—
24 Aug 2026, 09:57
Capital RaisingMS
20 Aug 2026, 09:37
Trading Halt / SuspensionMS
18 Aug 2026, 09:47
Company UpdateMS
30 July 2026, 11:24
Presentations—
30 July 2026, 08:30
Quarterly ReportsMS
28 July 2026, 08:40
Presentations—
27 July 2026, 08:55
Company UpdateMS
10 June 2026, 09:31
Presentations—
4 June 2026, 09:08
Company UpdateMS
2 June 2026, 08:23
Company UpdateMS
19 May 2026, 16:34
Securities Administration—
19 May 2026, 16:31
Securities Administration—
14 May 2026, 09:19
Company UpdateMS
7 May 2026, 10:08
Presentations—
7 May 2026, 09:21
Securities Administration—
7 May 2026, 09:21
Capital RaisingMS
5 May 2026, 10:49
Trading Halt / SuspensionMS
5 May 2026, 09:54
Trading Halt / SuspensionMS
30 Apr 2026, 17:10
Securities Administration—
30 Apr 2026, 16:23
Quarterly ReportsMS
21 Apr 2026, 08:16
Company UpdateMS
16 Apr 2026, 09:12
Periodic ReportsMS
15 Apr 2026, 09:20
Mergers & AcquisitionsMS
9 Apr 2026, 17:10
Director Interests—
9 Apr 2026, 17:10
Director Interests—
9 Apr 2026, 17:09
Director Interests—
9 Apr 2026, 17:08
Director Interests—
8 Apr 2026, 17:02
Securities Administration—
8 Apr 2026, 16:53
Securities Administration—
7 Apr 2026, 09:44
Securities Administration—
7 Apr 2026, 09:44
Securities Administration—
7 Apr 2026, 09:44
Securities Administration—
7 Apr 2026, 09:43
Company UpdateMS
2 Apr 2026, 18:18
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 25 Sept 2026, 17:05 | Quoted Option Expiry | Securities Administration | — | 06009 | |
| 7 Sept 2026, 18:51 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 7 Sept 2026, 18:49 | Application for quotation of securities - XEN | Securities Administration | — | 06020 | |
| 1 Sept 2026, 17:12 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 1 Sept 2026, 16:56 | Application for quotation of securities - XEN | Securities Administration | — | 06020 | |
| 31 Aug 2026, 18:44 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 17:50 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 24 Aug 2026, 09:57 | Proposed issue of securities - XEN | Securities Administration | — | 06013 | |
| 24 Aug 2026, 09:57 | Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth | Capital Raising | MS | 06003, 09014 | |
| 20 Aug 2026, 09:37 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 18 Aug 2026, 09:47 | $5m Offtake Agreement Expands OTC-Medicine Business | Company Update | MS | 11001 | |
| 30 July 2026, 11:24 | Investor Presentation | Presentations | — | 03026 | |
| 30 July 2026, 08:30 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 28 July 2026, 08:40 | Investor Webinar | Presentations | — | 14014 | |
| 27 July 2026, 08:55 | $12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL | Company Update | MS | 11001 | |
| 10 June 2026, 09:31 | Xenitra Investor Webinar | Presentations | — | 14014 | |
| 4 June 2026, 09:08 | $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks | Company Update | MS | 11001 | |
| 2 June 2026, 08:23 | XEN Appointed as Exclusive Biomiq Skincare China Distributor | Company Update | MS | 11001 | |
| 19 May 2026, 16:34 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 19 May 2026, 16:31 | Application for quotation of securities - XEN | Securities Administration | — | 06020 | |
| 14 May 2026, 09:19 | Product sales of $500k in first month of OPAL token launch | Company Update | MS | 11001 | |
| 7 May 2026, 10:08 | Investor Presentation | Presentations | — | 03026 | |
| 7 May 2026, 09:21 | Proposed issue of securities - XEN | Securities Administration | — | 06013 | |
| 7 May 2026, 09:21 | $1.25m Raised to Support Next Phase of Growth | Capital Raising | MS | 06003, 09014 | |
| 5 May 2026, 10:49 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 5 May 2026, 09:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 30 Apr 2026, 17:10 | Change of Address | Securities Administration | — | 12002, 12003 | |
| 30 Apr 2026, 16:23 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 08:16 | OPAL token launch of EZZ products sells $100k in first week | Company Update | MS | 11001 | |
| 16 Apr 2026, 09:12 | Q3 Sales rise by over 305% to $8.3m | Periodic Reports | MS | 03014 | |
| 15 Apr 2026, 09:20 | Acquisition of Fukang OTC Pharmacy | Mergers & Acquisitions | MS | 07001 | |
| 9 Apr 2026, 17:10 | Change of Director's Interest Notice - ZG | Director Interests | — | 02009 | |
| 9 Apr 2026, 17:10 | Change of Director's Interest Notice - LL | Director Interests | — | 02009 | |
| 9 Apr 2026, 17:09 | Change of Director's Interest Notice - CH | Director Interests | — | 02009 | |
| 9 Apr 2026, 17:08 | Change of Director's Interest Notice - AN | Director Interests | — | 02009 | |
| 8 Apr 2026, 17:02 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 8 Apr 2026, 16:53 | Application for quotation of securities - XEN | Securities Administration | — | 06020 | |
| 7 Apr 2026, 09:44 | Notification regarding unquoted securities - XEN | Securities Administration | — | 06021 | |
| 7 Apr 2026, 09:44 | Notification regarding unquoted securities - XEN | Securities Administration | — | 06021 | |
| 7 Apr 2026, 09:44 | Notification regarding unquoted securities - XEN | Securities Administration | — | 06021 | |
| 7 Apr 2026, 09:43 | OPAL Token & Xen Shop Launch - Next-Gen Digital Commerce | Company Update | MS | 11001 | |
| 2 Apr 2026, 18:18 | Notification regarding unquoted securities - XEN | Securities Administration | — | 06021 |
1–42 of 42
1 / 1